Sign In
Buy RVTY
$101.07
+0.680 (+0.677%)
At Close: Jun 03, 2026
Revvity (RVTY) Reports Q1 Earnings: What Key Metrics Have to Say
10:30am, Monday, 29'th Apr 2024
While the top- and bottom-line numbers for Revvity (RVTY) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare t
Revvity (RVTY) Beats Q1 Earnings and Revenue Estimates
08:11am, Monday, 29'th Apr 2024
Revvity (RVTY) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.94 per share. This compares to earnings of $1.01 per share a year ago.
Revvity beats quarterly estimates on demand for diagnostic equipment
07:42am, Monday, 29'th Apr 2024
Revvity on Monday beat Wall Street estimates for its quarterly profit and revenue, helped by better-than-expected demand for equipment in its diagnostics unit.
Revvity Announces Financial Results for the First Quarter of 2024
06:00am, Monday, 29'th Apr 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today reported financial results for the first quarter ended March 31, 2024. The Company reported GAAP earnings per share of $0.21, as comp
Revvity Board Declares Quarterly Dividend
04:15pm, Thursday, 25'th Apr 2024
WALTHAM, Mass.--(BUSINESS WIRE)--The Board of Directors of Revvity (NYSE: RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on August 9, 2
Revvity's (RVTY) New Launch to Boost Tuberculosis Testing
01:50pm, Thursday, 25'th Apr 2024
Revvity's (RVTY) latest offering is likely to provide a new and improved workflow to lower hands-on time and enable increased lab productivity.
Revvity to Present at BofA Securities 2024 Health Care Conference
08:00am, Thursday, 25'th Apr 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) will present at the BofA Securities 2024 Health Care Conference on Tuesday, May 14, 2024 at 8:40 a.m. PT in Las Vegas, NV. Senior Vice Presi
Revvity Unveils a New Era of Automated Tuberculosis Testing
06:00am, Wednesday, 24'th Apr 2024
WALTHAM, Mass.--(BUSINESS WIRE)-- #TB--Revvity, Inc. (NYSE: RVTY) today announced the launch of the Auto-Pure 2400 liquid handler from Allsheng for use with the T-SPOT.TB test. The Auto-Pure 2400 plat
Revvity's (RVTY) Launch to Boost Pharma-Contract Partner Tie-Up
01:31pm, Tuesday, 16'th Apr 2024
Revvity's (RVTY) latest offering is likely to significantly accelerate the pace of drug innovation, with efficient data sharing into one seamless platform.
Revvity Signals Software's New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners
06:00am, Monday, 15'th Apr 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Today, Revvity, Inc. (NYSE: RVTY) announced that its software and informatics division, Revvity Signals, will launch Signals SynergyTM, a software solution designed to
Revvity (RVTY) Stock Jumps 4.1%: Will It Continue to Soar?
11:06am, Wednesday, 10'th Apr 2024
Revvity (RVTY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in
Revvity To Hold Earnings Call on Monday, April 29, 2024
08:00am, Thursday, 04'th Apr 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced that it will release its first quarter 2024 financial results prior to market open on Monday, April 29, 2024. The Company w
Preliminary Injunction Granted to Enforce Revvity's Rights and Cloud Software Group's Obligations Related to Spotfire Software
06:00am, Tuesday, 02'nd Apr 2024
WALTHAM, Mass.--(BUSINESS WIRE)--Today, Revvity, Inc. (NYSE: RVTY) announced that the Massachusetts Superior Court has granted a preliminary injunction compelling Cloud Software Group (CSG) to comply
Three Reasons to Retain Revvity (RVTY) Stock in Your Portfolio
02:05pm, Monday, 01'st Apr 2024
Revvity's (RVTY) strong product portfolio raises optimism about the stock.
Revvity's (RVTY) New Launch to Boost Research Productivity
10:41am, Thursday, 21'st Mar 2024
Revvity's (RVTY) latest next-generation suite is likely to enhance research productivity and innovation.
